Prostatis Group’s JPMorgan Equity Premium Income ETF JEPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,019
Closed -$401K 165
2025
Q1
$401K Sell
7,019
-407
-5% -$23.7K 0.13% 102
2024
Q4
$427K Sell
7,426
-2,757
-27% -$164K 0.12% 111
2024
Q3
$606K Buy
10,183
+323
+3% +$18.6K 0.2% 84
2024
Q2
$559K Sell
9,860
-576
-6% -$32.6K 0.2% 90
2024
Q1
$604K Sell
10,436
-35,322
-77% -$1.99M 0.23% 83
2023
Q4
$2.52M Buy
45,758
+6,783
+17% +$366K 1.05% 29
2023
Q3
$2.14M Buy
38,975
+6,371
+20% +$351K 1.05% 19
2023
Q2
$1.8M Buy
32,604
+12,681
+64% +$693K 0.84% 30
2023
Q1
$1.09M Buy
19,923
+715
+4% +$38.8K 0.57% 46
2022
Q4
$1.05M Buy
19,208
+3,200
+20% +$174K 0.64% 42
2022
Q3
$820K Buy
+16,008
New +$891K 0.95% 29

Other funds holding JEPI

Prostatis Group's JEPI Position: Q2 2025 in Review

Prostatis Group sold out of JPMorgan Equity Premium Income ETF (JEPI) in Q2 2025, closing a stake of 7,019 shares — an estimated $401K sold.

Prostatis Group first reported a position in JEPI in Q3 2022 and held it in 11 quarters. The position peaked at $2.52M in Q4 2023. 1,286 funds tracked by Wall St. Rank hold JEPI as of Q2 2025.

  • Prostatis Group reported no remaining JPMorgan Equity Premium Income ETF position as of Q2 2025 after selling out during the quarter.
  • Prostatis Group sold 7,019 JPMorgan Equity Premium Income ETF shares in Q2 2025, an estimated $401K.
  • Prostatis Group first reported a position in JPMorgan Equity Premium Income ETF in Q3 2022 and held it in 11 quarters.
  • Prostatis Group's JPMorgan Equity Premium Income ETF position peaked at $2.52M in Q4 2023.
  • 1,286 funds tracked by Wall St. Rank held JPMorgan Equity Premium Income ETF as of Q2 2025.

Based on Prostatis Group's 13F filing for Q2 2025, filed 25 Jul 2025.